Application Sponsors
ANDA 091359 | LANNETT CO INC | |
Marketing Status
Application Products
001 | CAPSULE;ORAL | 30MG | 0 | PHENTERMINE HYDROCHLORIDE | PHENTERMINE HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 2010-07-16 | |
LABELING; Labeling | SUPPL | 2 | AP | 2012-04-19 | |
LABELING; Labeling | SUPPL | 3 | AP | 2012-12-05 | STANDARD |
LABELING; Labeling | SUPPL | 6 | AP | 2017-05-31 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 2 | Null | 7 |
SUPPL | 3 | Null | 7 |
SUPPL | 6 | Null | 15 |
CDER Filings
LANNETT CO INC
cder:Array
(
[0] => Array
(
[ApplNo] => 91359
[companyName] => LANNETT CO INC
[docInserts] => ["",""]
[products] => [{"drugName":"PHENTERMINE HYDROCHLORIDE","activeIngredients":"PHENTERMINE HYDROCHLORIDE","strength":"30MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"PHENTERMINE HYDROCHLORIDE","submission":"PHENTERMINE HYDROCHLORIDE","actionType":"30MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)